Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NovaBay Pharmaceuticals (NBY) Inventory Average (2016 - 2024)

Historic Inventory Average for NovaBay Pharmaceuticals (NBY) over the last 12 years, with Q3 2024 value amounting to $586500.0.

  • NovaBay Pharmaceuticals' Inventory Average fell 8360.13% to $586500.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $586500.0, marking a year-over-year decrease of 8360.13%. This contributed to the annual value of $2.0 million for FY2023, which is 4084.42% down from last year.
  • According to the latest figures from Q3 2024, NovaBay Pharmaceuticals' Inventory Average is $586500.0, which was down 8360.13% from $681500.0 recorded in Q2 2024.
  • NovaBay Pharmaceuticals' Inventory Average's 5-year high stood at $3.9 million during Q3 2022, with a 5-year trough of $522000.0 in Q1 2020.
  • Moreover, its 5-year median value for Inventory Average was $825500.0 (2021), whereas its average is $1.9 million.
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 37662.02% in 2022, then tumbled by 8390.93% in 2024.
  • Quarter analysis of 5 years shows NovaBay Pharmaceuticals' Inventory Average stood at $696500.0 in 2020, then soared by 200.72% to $2.1 million in 2021, then surged by 79.16% to $3.8 million in 2022, then crashed by 46.78% to $2.0 million in 2023, then plummeted by 70.63% to $586500.0 in 2024.
  • Its last three reported values are $586500.0 in Q3 2024, $681500.0 for Q2 2024, and $582000.0 during Q1 2024.